-
Stiefel acquires eczema remedy currently in phase-3 trials in the U.S.
LONDON — Stiefel, a GlaxoSmithKline company, on Monday acquired the eczema remedy Toctino (alitretinoin) from Basilea Pharmaceutica.
“Toctino is an important and growing product that complements the Stiefel portfolio and offers a proven therapy for patients with a significant unmet medical need," stated Simon Jose, Stiefel president. "This acquisition gives us an immediate opportunity to develop and expand the availability of this new and innovative product of value, and reinforces Stiefel and GSK’s commitment to dermatology.”
-
Crown Dynamics introduces patented device to help decrease snoring
SCOTTSDALE, Ariz. — Crown Dynamics on Wednesday launched its patented Air Sleep/Snore product line. The products are infused with a proprietary blend of therapeutic essential oils shown to promote sleep while gently dilating nasal passages to help increase oxygen flow and decrease snoring.